November 29, 2024 Holiday Shopping Sets New Records With $6.1B Spent Online
November 25, 2024 Bitcoin Nears $100K: Crypto Revolution Reshapes Wall Street
November 18, 2024 Biden’s Missile Strategy: Escalation Or Path To Peace?
November 10, 2024 Wall Street Soars: Trump’s Victory Ignites Market Surge
Tesla: Declining Sales Growth And Potential Margin Compression
Apple: Why The Future Looks Far Less Secure
Amazon: Still A Buy Thanks To Bedrock And Trainium
Amazon: Not A Second-Tier AI Player Anymore, But I Need Better Numbers
December 9, 2024 When to Switch Payroll Solutions and How to Make a Smooth Transition
November 24, 2024 Latest Finance Management Regulations in Australia
November 24, 2024 Finance Management Education Resources
November 18, 2024 Best Backtesting Software For Traders
November 18, 2024 Best Forex Trading Tools
ImmunoGen (IMGN) stock forecast for 2025
Updated: December 8, 2024 (12:46)
Sector: HealthcareThe share price of ImmunoGen, Inc. (IMGN) now
50/200 Day Moving Average: $ / $
This figure corresponds to the Average Price over the previous 50/200 days. For ImmunoGen stocks, the 50-day moving average is the support level today.
For ImmunoGen stocks, the 200-day moving average is the support level today.
Are you interested in ImmunoGen, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the ImmunoGen stock price in 2025. How much will one ImmunoGen share be worth in 2025? Is it worth taking profit / loss on IMGN stock now or waiting? What are analysts' forecasts for ImmunoGen stock?
We forecast ImmunoGen stock performance using neural networks based on historical data on IMGN stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
ImmunoGen, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for ImmunoGen analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).
Historical and forecast chart of ImmunoGen, Inc. stock
The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the IMGN stock price can be found in the table below.
ImmunoGen, Inc., a clinical-stage biotechnology company, is developing antibody-drug conjugate (ADC) therapies for cancer. Its candidate products include mirvetuximab soravtansine, an alpha-folate receptor-targeted ADC that is in phase III clinical trials for the treatment of platinum-resistant ovarian cancer; and IMGN632, an ADC targeting CD123, which is in phase I clinical trials for the treatment of AML and blast plasmacytoid dendritic cell neoplasms.
ImmunoGen (IMGN) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 27.14 | 18.63 | 33.79 | 44.86 % |
| Feb | 34.56 | 23.92 | 38.89 | 38.49 % |
| Mar | 26.29 | 22.54 | 29.88 | 24.57 % |
| Apr | 27.34 | 23.44 | 35.75 | 34.43 % |
| May | 30.30 | 20.11 | 43.25 | 53.51 % |
| Jun | 34.61 | 21.79 | 46.45 | 53.09 % |
| Jul | 34.02 | 26.65 | 49.53 | 46.19 % |
| Aug | 41.78 | 27.73 | 59.40 | 53.32 % |
| Sep | 45.59 | 33.12 | 60.14 | 44.94 % |
| Oct | 64.82 | 54.10 | 79.23 | 31.71 % |
| Nov | 30.46 | 19.87 | 37.75 | 47.37 % |
| Dec | 30.28 | 23.55 | 37.36 | 36.96 % |
ImmunoGen information and performance
N/A
Market capitalization of the ImmunoGen, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of IMGN shares in the company outstanding by the market price of one share.
EBITDA of ImmunoGen is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
ImmunoGen price target for 2025 by month
Target values for the price of one ImmunoGen share for Jan 2025.
In Jan, the Positive dynamics for ImmunoGen, Inc. shares will prevail with possible monthly volatility of 44.864% volatility is expected.
Pessimistic target level: 18.63
Optimistic target level: 33.79
Target values for the price of one ImmunoGen share for Feb 2025.
In Feb, the Positive dynamics for ImmunoGen, Inc. shares will prevail with possible monthly volatility of 38.493% volatility is expected.
Pessimistic target level: 23.92
Optimistic target level: 38.89
Target values for the price of one ImmunoGen share for Mar 2025.
In Mar, the Negative dynamics for ImmunoGen, Inc. shares will prevail with possible monthly volatility of 24.569% volatility is expected.
Pessimistic target level: 22.54
Optimistic target level: 29.88
Target values for the price of one ImmunoGen share for Apr 2025.
In Apr, the Positive dynamics for ImmunoGen, Inc. shares will prevail with possible monthly volatility of 34.432% volatility is expected.
Pessimistic target level: 23.44
Optimistic target level: 35.75
Target values for the price of one ImmunoGen share for May 2025.
In May, the Positive dynamics for ImmunoGen, Inc. shares will prevail with possible monthly volatility of 53.506% volatility is expected.
Pessimistic target level: 20.11
Optimistic target level: 43.25
Target values for the price of one ImmunoGen share for Jun 2025.
In Jun, the Positive dynamics for ImmunoGen, Inc. shares will prevail with possible monthly volatility of 53.092% volatility is expected.
Pessimistic target level: 21.79
Optimistic target level: 46.45
Target values for the price of one ImmunoGen share for Jul 2025.
In Jul, the Negative dynamics for ImmunoGen, Inc. shares will prevail with possible monthly volatility of 46.195% volatility is expected.
Pessimistic target level: 26.65
Optimistic target level: 49.53
Target values for the price of one ImmunoGen share for Aug 2025.
In Aug, the Positive dynamics for ImmunoGen, Inc. shares will prevail with possible monthly volatility of 53.320% volatility is expected.
Pessimistic target level: 27.73
Optimistic target level: 59.40
Target values for the price of one ImmunoGen share for Sep 2025.
In Sep, the Positive dynamics for ImmunoGen, Inc. shares will prevail with possible monthly volatility of 44.936% volatility is expected.
Pessimistic target level: 33.12
Optimistic target level: 60.14
Target values for the price of one ImmunoGen share for Oct 2025.
In Oct, the Positive dynamics for ImmunoGen, Inc. shares will prevail with possible monthly volatility of 31.711% volatility is expected.
Pessimistic target level: 54.10
Optimistic target level: 79.23
Target values for the price of one ImmunoGen share for Nov 2025.
In Nov, the Negative dynamics for ImmunoGen, Inc. shares will prevail with possible monthly volatility of 47.370% volatility is expected.
Pessimistic target level: 19.87
Optimistic target level: 37.75
Target values for the price of one ImmunoGen share for Dec 2025.
In Dec, the Negative dynamics for ImmunoGen, Inc. shares will prevail with possible monthly volatility of 36.962% volatility is expected.
Pessimistic target level: 23.55
Optimistic target level: 37.36
